Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-05-2023 | Pleural Effusion | Case report

Dasatinib/nilotinib

Various toxicities: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Suyama T, et al. Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia. Journal of Clinical and Experimental Hematopathology 63: 43-48, No. 1, 2023. Available from: URL: http://doi.org/10.3960/jslrt.22041 Suyama T, et al. Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia. Journal of Clinical and Experimental Hematopathology 63: 43-48, No. 1, 2023. Available from: URL: http://​doi.​org/​10.​3960/​jslrt.​22041
Metadata
Title
Dasatinib/nilotinib
Various toxicities: case report
Publication date
01-05-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38397-0

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Antineoplastics

Case report

Carbamazepine

Case report

BCG/isoniazid

Case report

Pegfilgrastim

Case report

Elasomeran